Cargando…
Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding...
Autores principales: | Jaworski, Juan Pablo, Vendrell, Alejandrina, Chiavenna, Sebastián Matias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225137/ https://www.ncbi.nlm.nih.gov/pubmed/28123384 http://dx.doi.org/10.3389/fimmu.2016.00661 |
Ejemplares similares
-
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021) -
Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
por: Sun, Ming, et al.
Publicado: (2016) -
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020) -
State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017) -
Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)